Thermal Ablation Devices

Thermal Ablation Devices

Global Thermal Ablation Devices Market to Reach US$8.8 Billion by 2030

The global market for Thermal Ablation Devices estimated at US$6.5 Billion in the year 2023, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Probes Component, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Systems Component segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 8.2% CAGR

The Thermal Ablation Devices market in the U.S. is estimated at US$1.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Thermal Ablation Devices Market - Key Trends and Drivers Summarized

Why Are Thermal Ablation Devices Becoming a Preferred Treatment Option?

Thermal ablation devices, which use heat to destroy abnormal tissues, have gained prominence as a minimally invasive treatment option for conditions such as cancer, cardiac arrhythmias, and chronic pain. The growing demand for non-invasive procedures has significantly boosted the adoption of these devices, particularly in oncology and cardiology. With patients increasingly seeking treatments that offer faster recovery times and fewer complications, thermal ablation has emerged as a viable alternative to traditional surgery. Moreover, technological advancements in microwave, radiofrequency, and laser-based ablation systems have enhanced the precision and effectiveness of these devices, making them more popular among healthcare providers.

What Role Do Segments and End-Use Applications Play in the Market?

The thermal ablation devices market is divided into various segments based on technology, application, and end-users. In terms of technology, microwave and radiofrequency ablation devices dominate the market, with radiofrequency ablation being widely used for treating liver, lung, and kidney tumors. The application segments are primarily driven by oncology, where thermal ablation is used to treat solid tumors, and cardiology, where it is employed to manage arrhythmias such as atrial fibrillation. Other significant applications include pain management and gynecology. End-users in this market include hospitals, specialty clinics, and ambulatory surgical centers, with hospitals holding the largest share due to the growing number of outpatient procedures involving ablation devices.

What Technological Innovations Are Transforming Thermal Ablation Devices?

Technological advancements are playing a pivotal role in the evolution of thermal ablation devices. Innovations such as real-time image guidance, improved energy delivery mechanisms, and the integration of robotics are driving the development of more precise and effective ablation systems. For instance, the use of advanced imaging technologies such as MRI and CT scans during ablation procedures allows for greater accuracy in targeting and treating tumors or abnormal tissues. Additionally, the integration of AI and machine learning is enabling physicians to optimize treatment protocols and improve patient outcomes. The development of portable ablation systems is another trend that is making these treatments more accessible in outpatient settings, expanding the market further.

What Are the Main Growth Drivers in the Thermal Ablation Devices Market?

The growth in the thermal ablation devices market is driven by several factors, including the rising prevalence of cancer and cardiovascular diseases, the growing demand for minimally invasive treatments, and the increasing adoption of advanced ablation technologies. The expansion of outpatient surgical procedures, particularly in oncology and cardiology, is also contributing to market growth. Additionally, advancements in imaging and real-time monitoring technologies have improved the efficacy of thermal ablation treatments, which is driving adoption among healthcare providers. Regulatory approvals for new and innovative ablation devices are further boosting market growth. Moreover, increasing awareness about the benefits of non-invasive procedures and the reduction in healthcare costs associated with shorter hospital stays are key factors propelling market expansion.

Select Competitors (Total 31 Featured) -

• Abbott Laboratories, Inc.
• AngioDynamics, Inc.
• AtriCure, Inc.
• Boston Scientific Corporation
• Halyard Health, Inc.
• Hologic, Inc.
• Johnson & Johnson
• Medtronic PLC
• Olympus Corporation
• Smith & Nephew PLC
• Stryker Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.